| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Fatima Abu-Tair, Jürgen Kopitz, Niels Bergeman. Clozapine augmented with aripiprazole in 5 patients with schizophrenia. Journal of clinical psychopharmacology. vol 26. issue 6. 2007-02-07. PMID:17110831. |
clozapine augmented with aripiprazole in 5 patients with schizophrenia. |
2007-02-07 |
2023-08-12 |
Not clear |
| Shôn W Lewis, Thomas R E Barnes, Linda Davies, Robin M Murray, Graham Dunn, Karen P Hayhurst, Alison Markwick, Helen Lloyd, Peter B Jone. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophrenia bulletin. vol 32. issue 4. 2007-01-29. PMID:16540702. |
randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. |
2007-01-29 |
2023-08-12 |
human |
| Shôn W Lewis, Thomas R E Barnes, Linda Davies, Robin M Murray, Graham Dunn, Karen P Hayhurst, Alison Markwick, Helen Lloyd, Peter B Jone. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophrenia bulletin. vol 32. issue 4. 2007-01-29. PMID:16540702. |
there is good evidence that clozapine is more efficacious than first-generation antipsychotic drugs in resistant schizophrenia. |
2007-01-29 |
2023-08-12 |
human |
| Shôn W Lewis, Thomas R E Barnes, Linda Davies, Robin M Murray, Graham Dunn, Karen P Hayhurst, Alison Markwick, Helen Lloyd, Peter B Jone. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophrenia bulletin. vol 32. issue 4. 2007-01-29. PMID:16540702. |
in conclusion, in people with schizophrenia with poor treatment response to 2 or more antipsychotic drugs, there is an advantage to commencing clozapine rather than other sga drugs in terms of symptom improvement over 1 year. |
2007-01-29 |
2023-08-12 |
human |
| Mary F Brunette, Robert E Drake, Haiyi Xie, Gregory J McHugo, Alan I Gree. Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders. Schizophrenia bulletin. vol 32. issue 4. 2007-01-29. PMID:16782758. |
clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders. |
2007-01-29 |
2023-08-12 |
Not clear |
| Stephen M Beard, Fiona Maciver, Johannes Clouth, Eckart Rüthe. A decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in Germany. The European journal of health economics : HEPAC : health economics in prevention and care. vol 7. issue 3. 2007-01-09. PMID:16896764. |
second-generation atypical antipsychotics such as clozapine, olanzapine, risperidone, quetiapine, ziprasidone, amisulpride and ariprazole offer the potential to reduce the significant health care resource demands in the treatment of schizophrenia through improved levels of initial clinical response and reduced levels of long-term acute relapse. |
2007-01-09 |
2023-08-12 |
Not clear |
| Edoardo Spina, Concetta D'Arrigo, Gaetana Migliardi, Vincenza Santoro, Maria Rosaria Muscatello, Umberto Micò, Giuseppina D'Amico, Emilio Perucc. Effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder. Therapeutic drug monitoring. vol 28. issue 5. 2007-01-09. PMID:17038872. |
effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder. |
2007-01-09 |
2023-08-12 |
Not clear |
| Edoardo Spina, Concetta D'Arrigo, Gaetana Migliardi, Vincenza Santoro, Maria Rosaria Muscatello, Umberto Micò, Giuseppina D'Amico, Emilio Perucc. Effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder. Therapeutic drug monitoring. vol 28. issue 5. 2007-01-09. PMID:17038872. |
the effect of lamotrigine on the steady-state plasma concentrations of the atypical antipsychotics clozapine, olanzapine, and risperidone was investigated in patients with schizophrenia or bipolar disorder stabilized on chronic treatment with clozapine (200-500 mg/day; n = 11), risperidone (3-6 mg/day; n = 10) or olanzapine (10-20 mg/day; n = 14)). |
2007-01-09 |
2023-08-12 |
Not clear |
| Berna Binnur Kivircik Akdede, A Elif Anil Yağcioğlu, Köksal Alptekin, Tolga I Turgut, Mevhibe Tümüklü, M Kâzim Yazici, Karu Jayathilake, Zeliha Tunca, Ahmet Göğüş, Herbert Y Meltze. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition. The Journal of clinical psychiatry. vol 67. issue 12. 2007-01-09. PMID:17194269. |
a double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition. |
2007-01-09 |
2023-08-12 |
Not clear |
| Berna Binnur Kivircik Akdede, A Elif Anil Yağcioğlu, Köksal Alptekin, Tolga I Turgut, Mevhibe Tümüklü, M Kâzim Yazici, Karu Jayathilake, Zeliha Tunca, Ahmet Göğüş, Herbert Y Meltze. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition. The Journal of clinical psychiatry. vol 67. issue 12. 2007-01-09. PMID:17194269. |
the aim of this study was to compare the effect of risperidone or placebo on cognitive function in patients with schizophrenia who were previously treated with clozapine monotherapy. |
2007-01-09 |
2023-08-12 |
Not clear |
| Marc Ziegenbein, Georg Wittmann, Stefan Krop. Aripiprazole augmentation of clozapine in treatment-resistant schizophrenia: a clinical observation. Clinical drug investigation. vol 26. issue 3. 2007-01-03. PMID:17163242. |
aripiprazole augmentation of clozapine in treatment-resistant schizophrenia: a clinical observation. |
2007-01-03 |
2023-08-12 |
Not clear |
| Jenny-Kay Sharpe, Terry J Stedman, Nuala M Byrne, Connie Wishart, Andrew P Hill. Energy expenditure and physical activity in clozapine use: implications for weight management. The Australian and New Zealand journal of psychiatry. vol 40. issue 9. 2006-12-20. PMID:16911758. |
the current study of men with schizophrenia taking clozapine aimed to measure total energy expenditure (tee) and energy expended on physical activity--activity energy expenditure (aee) and to consider the clinical implications of the findings. |
2006-12-20 |
2023-08-12 |
Not clear |
| W W Blessing, A Zilm, Y Ootsuk. Clozapine reverses increased brown adipose tissue thermogenesis induced by 3,4-methylenedioxymethamphetamine and by cold exposure in conscious rats. Neuroscience. vol 141. issue 4. 2006-12-04. PMID:16814930. |
clozapine's marked inhibition of ibat thermogenesis may provide a clue to its marked tendency to cause obesity when used to treat humans with mental disorders including schizophrenia. |
2006-12-04 |
2023-08-12 |
rat |
| T Tényi, V Vörö. Successful switch to olanzapine after rhabdomyolysis caused by water intoxication and clozapine use. Pharmacopsychiatry. vol 39. issue 4. 2006-11-30. PMID:16871473. |
the 46-year-old patient with the diagnosis of schizophrenia paranoid type, who had been on clozapine treatment for the previous 4 years, was admitted with the symptoms of generalized seizure and vomiting, and as severe hyponatremia was proved, its correction with the parallel use of clozapine treatment was done. |
2006-11-30 |
2023-08-12 |
Not clear |
| Ana Maria Sertori Durão, Maria Conceição Bernardo de Mello e Souz. [Schizophrenia patients' daily life after the use of clozapine and group accompaniment: Family's view]. Revista latino-americana de enfermagem. vol 14. issue 4. 2006-11-03. PMID:16967166. |
[schizophrenia patients' daily life after the use of clozapine and group accompaniment: family's view]. |
2006-11-03 |
2023-08-12 |
Not clear |
| Ana Maria Sertori Durão, Maria Conceição Bernardo de Mello e Souz. [Schizophrenia patients' daily life after the use of clozapine and group accompaniment: Family's view]. Revista latino-americana de enfermagem. vol 14. issue 4. 2006-11-03. PMID:16967166. |
this study described the daily life of schizophrenia patients after the use of clozapine and group accompaniment from the perspective of family members. |
2006-11-03 |
2023-08-12 |
Not clear |
| Ana Maria Sertori Durão, Maria Conceição Bernardo de Mello e Souz. [Schizophrenia patients' daily life after the use of clozapine and group accompaniment: Family's view]. Revista latino-americana de enfermagem. vol 14. issue 4. 2006-11-03. PMID:16967166. |
the research population consisted of 11 family members who most frequently accompanied 11 schizophrenia patients who participate in the group and use clozapine. |
2006-11-03 |
2023-08-12 |
Not clear |
| Hsien-Yuan Lane, Chieh-Liang Huang, Po-Lun Wu, Yi-Ching Liu, Yue-Cune Chang, Pao-Yen Lin, Po-Wei Chen, Guochuan Tsa. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia. Biological psychiatry. vol 60. issue 6. 2006-11-01. PMID:16780811. |
glycine transporter i inhibitor, n-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia. |
2006-11-01 |
2023-08-12 |
Not clear |
| Branimir Margetić, Branka Aukst-Margetić, Tija Zarković-Palija. Successful treatment of polydipsia, water intoxication, and delusional jealousy in an alcohol dependent patient with clozapine. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 7. 2006-10-31. PMID:16600455. |
the beneficial effect of clozapine on polydipsia and water intoxication in patients with schizophrenia has been demonstrated many times. |
2006-10-31 |
2023-08-12 |
Not clear |
| Daniel J Luchin. In the aftermath of CATIE: how should administrators value atypical antipsychotic medications? Administration and policy in mental health. vol 33. issue 5. 2006-10-31. PMID:16688482. |
although there is evidence that the atypical antipsychotic, clozapine, may lead to cost savings in patients with refractory schizophrenia the cost-effectiveness of the other atypical antipsychotics remains in question. |
2006-10-31 |
2023-08-12 |
Not clear |